Atlas Trials

A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease

Clinical trial NCT02637141 · COMPLETED

Trial details

NCT number
NCT02637141
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Celiac Disease
Start date
2016-04-13
Primary completion
2017-02-15
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.